Global Lancets Market Insights, Forecast to 2026
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Lancets 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Lancets 3900 industry.
Based on our recent survey, we have several different scenarios about the Lancets 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2100.7 million in 2019. The market size of Lancets 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lancets market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lancets market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Lancets market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Lancets market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Lancets market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Lancets market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lancets market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lancets market.
The following manufacturers are covered in this report:
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Lancets 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Lancets 3900 industry.
Based on our recent survey, we have several different scenarios about the Lancets 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2100.7 million in 2019. The market size of Lancets 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lancets market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lancets market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Lancets market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Lancets market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Lancets market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Lancets market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lancets market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lancets market.
The following manufacturers are covered in this report:
- Roche
- Lifescan
- BD
- Bayer
- Abbott
- B. Braun
- ARKRAY
- Terumo
- I-SENS
- Nipro
- Omron
- Infopia
- AgaMatrix
- Smiths Medical
- Sarstedt
- SANNUO
- Yicheng
- Yuwell
- Greiner Bio One
- Edan
- Narang Medical
- Safety Lancets
- Homecare Lancets
- Cholesterol Tests
- Glucose Tests
- Others
1 STUDY COVERAGE
1.1 Lancets Product Introduction
1.2 Market Segments
1.3 Key Lancets Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Lancets Market Size Growth Rate by Type
1.4.2 Safety Lancets
1.4.3 Homecare Lancets
1.5 Market by Application
1.5.1 Global Lancets Market Size Growth Rate by Application
1.5.2 Cholesterol Tests
1.5.3 Glucose Tests
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Lancets Industry Impact
1.6.1 How the Covid-19 is Affecting the Lancets Industry
1.6.1.1 Lancets Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Lancets Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Lancets Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Lancets Market Size Estimates and Forecasts
2.1.1 Global Lancets Revenue 2015-2026
2.1.2 Global Lancets Sales 2015-2026
2.2 Lancets Market Size by Region: 2020 Versus 2026
2.2.1 Global Lancets Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Lancets Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL LANCETS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Lancets Sales by Manufacturers
3.1.1 Lancets Sales by Manufacturers (2015-2020)
3.1.2 Lancets Sales Market Share by Manufacturers (2015-2020)
3.2 Lancets Revenue by Manufacturers
3.2.1 Lancets Revenue by Manufacturers (2015-2020)
3.2.2 Lancets Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Lancets Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Lancets Revenue in 2019
3.2.5 Global Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Lancets Price by Manufacturers
3.4 Lancets Manufacturing Base Distribution, Product Types
3.4.1 Lancets Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lancets Product Type
3.4.3 Date of International Manufacturers Enter into Lancets Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Lancets Market Size by Type (2015-2020)
4.1.1 Global Lancets Sales by Type (2015-2020)
4.1.2 Global Lancets Revenue by Type (2015-2020)
4.1.3 Lancets Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Lancets Market Size Forecast by Type (2021-2026)
4.2.1 Global Lancets Sales Forecast by Type (2021-2026)
4.2.2 Global Lancets Revenue Forecast by Type (2021-2026)
4.2.3 Lancets Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Lancets Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Lancets Market Size by Application (2015-2020)
5.1.1 Global Lancets Sales by Application (2015-2020)
5.1.2 Global Lancets Revenue by Application (2015-2020)
5.1.3 Lancets Price by Application (2015-2020)
5.2 Lancets Market Size Forecast by Application (2021-2026)
5.2.1 Global Lancets Sales Forecast by Application (2021-2026)
5.2.2 Global Lancets Revenue Forecast by Application (2021-2026)
5.2.3 Global Lancets Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Lancets by Country
6.1.1 North America Lancets Sales by Country
6.1.2 North America Lancets Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Lancets Market Facts & Figures by Type
6.3 North America Lancets Market Facts & Figures by Application
7 EUROPE
7.1 Europe Lancets by Country
7.1.1 Europe Lancets Sales by Country
7.1.2 Europe Lancets Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Lancets Market Facts & Figures by Type
7.3 Europe Lancets Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Lancets by Region
8.1.1 Asia Pacific Lancets Sales by Region
8.1.2 Asia Pacific Lancets Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Lancets Market Facts & Figures by Type
8.3 Asia Pacific Lancets Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Lancets by Country
9.1.1 Latin America Lancets Sales by Country
9.1.2 Latin America Lancets Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Lancets Market Facts & Figures by Type
9.3 Central & South America Lancets Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Lancets by Country
10.1.1 Middle East and Africa Lancets Sales by Country
10.1.2 Middle East and Africa Lancets Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Lancets Market Facts & Figures by Type
10.3 Middle East and Africa Lancets Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Lancets Products Offered
11.1.5 Roche Recent Development
11.2 Lifescan
11.2.1 Lifescan Corporation Information
11.2.2 Lifescan Description, Business Overview and Total Revenue
11.2.3 Lifescan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Lifescan Lancets Products Offered
11.2.5 Lifescan Recent Development
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Description, Business Overview and Total Revenue
11.3.3 BD Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BD Lancets Products Offered
11.3.5 BD Recent Development
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description, Business Overview and Total Revenue
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Lancets Products Offered
11.4.5 Bayer Recent Development
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description, Business Overview and Total Revenue
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott Lancets Products Offered
11.5.5 Abbott Recent Development
11.6 B. Braun
11.6.1 B. Braun Corporation Information
11.6.2 B. Braun Description, Business Overview and Total Revenue
11.6.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
11.6.4 B. Braun Lancets Products Offered
11.6.5 B. Braun Recent Development
11.7 ARKRAY
11.7.1 ARKRAY Corporation Information
11.7.2 ARKRAY Description, Business Overview and Total Revenue
11.7.3 ARKRAY Sales, Revenue and Gross Margin (2015-2020)
11.7.4 ARKRAY Lancets Products Offered
11.7.5 ARKRAY Recent Development
11.8 Terumo
11.8.1 Terumo Corporation Information
11.8.2 Terumo Description, Business Overview and Total Revenue
11.8.3 Terumo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Terumo Lancets Products Offered
11.8.5 Terumo Recent Development
11.9 I-SENS
11.9.1 I-SENS Corporation Information
11.9.2 I-SENS Description, Business Overview and Total Revenue
11.9.3 I-SENS Sales, Revenue and Gross Margin (2015-2020)
11.9.4 I-SENS Lancets Products Offered
11.9.5 I-SENS Recent Development
11.10 Nipro
11.10.1 Nipro Corporation Information
11.10.2 Nipro Description, Business Overview and Total Revenue
11.10.3 Nipro Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Nipro Lancets Products Offered
11.10.5 Nipro Recent Development
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Lancets Products Offered
11.1.5 Roche Recent Development
11.12 Infopia
11.12.1 Infopia Corporation Information
11.12.2 Infopia Description, Business Overview and Total Revenue
11.12.3 Infopia Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Infopia Products Offered
11.12.5 Infopia Recent Development
11.13 AgaMatrix
11.13.1 AgaMatrix Corporation Information
11.13.2 AgaMatrix Description, Business Overview and Total Revenue
11.13.3 AgaMatrix Sales, Revenue and Gross Margin (2015-2020)
11.13.4 AgaMatrix Products Offered
11.13.5 AgaMatrix Recent Development
11.14 Smiths Medical
11.14.1 Smiths Medical Corporation Information
11.14.2 Smiths Medical Description, Business Overview and Total Revenue
11.14.3 Smiths Medical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Smiths Medical Products Offered
11.14.5 Smiths Medical Recent Development
11.15 Sarstedt
11.15.1 Sarstedt Corporation Information
11.15.2 Sarstedt Description, Business Overview and Total Revenue
11.15.3 Sarstedt Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sarstedt Products Offered
11.15.5 Sarstedt Recent Development
11.16 SANNUO
11.16.1 SANNUO Corporation Information
11.16.2 SANNUO Description, Business Overview and Total Revenue
11.16.3 SANNUO Sales, Revenue and Gross Margin (2015-2020)
11.16.4 SANNUO Products Offered
11.16.5 SANNUO Recent Development
11.17 Yicheng
11.17.1 Yicheng Corporation Information
11.17.2 Yicheng Description, Business Overview and Total Revenue
11.17.3 Yicheng Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Yicheng Products Offered
11.17.5 Yicheng Recent Development
11.18 Yuwell
11.18.1 Yuwell Corporation Information
11.18.2 Yuwell Description, Business Overview and Total Revenue
11.18.3 Yuwell Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Yuwell Products Offered
11.18.5 Yuwell Recent Development
11.19 Greiner Bio One
11.19.1 Greiner Bio One Corporation Information
11.19.2 Greiner Bio One Description, Business Overview and Total Revenue
11.19.3 Greiner Bio One Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Greiner Bio One Products Offered
11.19.5 Greiner Bio One Recent Development
11.20 Edan
11.20.1 Edan Corporation Information
11.20.2 Edan Description, Business Overview and Total Revenue
11.20.3 Edan Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Edan Products Offered
11.20.5 Edan Recent Development
11.21 Narang Medical
11.21.1 Narang Medical Corporation Information
11.21.2 Narang Medical Description, Business Overview and Total Revenue
11.21.3 Narang Medical Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Narang Medical Products Offered
11.21.5 Narang Medical Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Lancets Market Estimates and Projections by Region
12.1.1 Global Lancets Sales Forecast by Regions 2021-2026
12.1.2 Global Lancets Revenue Forecast by Regions 2021-2026
12.2 North America Lancets Market Size Forecast (2021-2026)
12.2.1 North America: Lancets Sales Forecast (2021-2026)
12.2.2 North America: Lancets Revenue Forecast (2021-2026)
12.2.3 North America: Lancets Market Size Forecast by Country (2021-2026)
12.3 Europe Lancets Market Size Forecast (2021-2026)
12.3.1 Europe: Lancets Sales Forecast (2021-2026)
12.3.2 Europe: Lancets Revenue Forecast (2021-2026)
12.3.3 Europe: Lancets Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Lancets Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Lancets Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Lancets Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Lancets Market Size Forecast by Region (2021-2026)
12.5 Latin America Lancets Market Size Forecast (2021-2026)
12.5.1 Latin America: Lancets Sales Forecast (2021-2026)
12.5.2 Latin America: Lancets Revenue Forecast (2021-2026)
12.5.3 Latin America: Lancets Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Lancets Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Lancets Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Lancets Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Lancets Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Lancets Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Lancets Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Lancets Product Introduction
1.2 Market Segments
1.3 Key Lancets Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Lancets Market Size Growth Rate by Type
1.4.2 Safety Lancets
1.4.3 Homecare Lancets
1.5 Market by Application
1.5.1 Global Lancets Market Size Growth Rate by Application
1.5.2 Cholesterol Tests
1.5.3 Glucose Tests
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Lancets Industry Impact
1.6.1 How the Covid-19 is Affecting the Lancets Industry
1.6.1.1 Lancets Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Lancets Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Lancets Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Lancets Market Size Estimates and Forecasts
2.1.1 Global Lancets Revenue 2015-2026
2.1.2 Global Lancets Sales 2015-2026
2.2 Lancets Market Size by Region: 2020 Versus 2026
2.2.1 Global Lancets Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Lancets Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL LANCETS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Lancets Sales by Manufacturers
3.1.1 Lancets Sales by Manufacturers (2015-2020)
3.1.2 Lancets Sales Market Share by Manufacturers (2015-2020)
3.2 Lancets Revenue by Manufacturers
3.2.1 Lancets Revenue by Manufacturers (2015-2020)
3.2.2 Lancets Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Lancets Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Lancets Revenue in 2019
3.2.5 Global Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Lancets Price by Manufacturers
3.4 Lancets Manufacturing Base Distribution, Product Types
3.4.1 Lancets Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lancets Product Type
3.4.3 Date of International Manufacturers Enter into Lancets Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Lancets Market Size by Type (2015-2020)
4.1.1 Global Lancets Sales by Type (2015-2020)
4.1.2 Global Lancets Revenue by Type (2015-2020)
4.1.3 Lancets Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Lancets Market Size Forecast by Type (2021-2026)
4.2.1 Global Lancets Sales Forecast by Type (2021-2026)
4.2.2 Global Lancets Revenue Forecast by Type (2021-2026)
4.2.3 Lancets Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Lancets Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Lancets Market Size by Application (2015-2020)
5.1.1 Global Lancets Sales by Application (2015-2020)
5.1.2 Global Lancets Revenue by Application (2015-2020)
5.1.3 Lancets Price by Application (2015-2020)
5.2 Lancets Market Size Forecast by Application (2021-2026)
5.2.1 Global Lancets Sales Forecast by Application (2021-2026)
5.2.2 Global Lancets Revenue Forecast by Application (2021-2026)
5.2.3 Global Lancets Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Lancets by Country
6.1.1 North America Lancets Sales by Country
6.1.2 North America Lancets Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Lancets Market Facts & Figures by Type
6.3 North America Lancets Market Facts & Figures by Application
7 EUROPE
7.1 Europe Lancets by Country
7.1.1 Europe Lancets Sales by Country
7.1.2 Europe Lancets Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Lancets Market Facts & Figures by Type
7.3 Europe Lancets Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Lancets by Region
8.1.1 Asia Pacific Lancets Sales by Region
8.1.2 Asia Pacific Lancets Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Lancets Market Facts & Figures by Type
8.3 Asia Pacific Lancets Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Lancets by Country
9.1.1 Latin America Lancets Sales by Country
9.1.2 Latin America Lancets Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Lancets Market Facts & Figures by Type
9.3 Central & South America Lancets Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Lancets by Country
10.1.1 Middle East and Africa Lancets Sales by Country
10.1.2 Middle East and Africa Lancets Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Lancets Market Facts & Figures by Type
10.3 Middle East and Africa Lancets Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Lancets Products Offered
11.1.5 Roche Recent Development
11.2 Lifescan
11.2.1 Lifescan Corporation Information
11.2.2 Lifescan Description, Business Overview and Total Revenue
11.2.3 Lifescan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Lifescan Lancets Products Offered
11.2.5 Lifescan Recent Development
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Description, Business Overview and Total Revenue
11.3.3 BD Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BD Lancets Products Offered
11.3.5 BD Recent Development
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description, Business Overview and Total Revenue
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Lancets Products Offered
11.4.5 Bayer Recent Development
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description, Business Overview and Total Revenue
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott Lancets Products Offered
11.5.5 Abbott Recent Development
11.6 B. Braun
11.6.1 B. Braun Corporation Information
11.6.2 B. Braun Description, Business Overview and Total Revenue
11.6.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
11.6.4 B. Braun Lancets Products Offered
11.6.5 B. Braun Recent Development
11.7 ARKRAY
11.7.1 ARKRAY Corporation Information
11.7.2 ARKRAY Description, Business Overview and Total Revenue
11.7.3 ARKRAY Sales, Revenue and Gross Margin (2015-2020)
11.7.4 ARKRAY Lancets Products Offered
11.7.5 ARKRAY Recent Development
11.8 Terumo
11.8.1 Terumo Corporation Information
11.8.2 Terumo Description, Business Overview and Total Revenue
11.8.3 Terumo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Terumo Lancets Products Offered
11.8.5 Terumo Recent Development
11.9 I-SENS
11.9.1 I-SENS Corporation Information
11.9.2 I-SENS Description, Business Overview and Total Revenue
11.9.3 I-SENS Sales, Revenue and Gross Margin (2015-2020)
11.9.4 I-SENS Lancets Products Offered
11.9.5 I-SENS Recent Development
11.10 Nipro
11.10.1 Nipro Corporation Information
11.10.2 Nipro Description, Business Overview and Total Revenue
11.10.3 Nipro Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Nipro Lancets Products Offered
11.10.5 Nipro Recent Development
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Lancets Products Offered
11.1.5 Roche Recent Development
11.12 Infopia
11.12.1 Infopia Corporation Information
11.12.2 Infopia Description, Business Overview and Total Revenue
11.12.3 Infopia Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Infopia Products Offered
11.12.5 Infopia Recent Development
11.13 AgaMatrix
11.13.1 AgaMatrix Corporation Information
11.13.2 AgaMatrix Description, Business Overview and Total Revenue
11.13.3 AgaMatrix Sales, Revenue and Gross Margin (2015-2020)
11.13.4 AgaMatrix Products Offered
11.13.5 AgaMatrix Recent Development
11.14 Smiths Medical
11.14.1 Smiths Medical Corporation Information
11.14.2 Smiths Medical Description, Business Overview and Total Revenue
11.14.3 Smiths Medical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Smiths Medical Products Offered
11.14.5 Smiths Medical Recent Development
11.15 Sarstedt
11.15.1 Sarstedt Corporation Information
11.15.2 Sarstedt Description, Business Overview and Total Revenue
11.15.3 Sarstedt Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sarstedt Products Offered
11.15.5 Sarstedt Recent Development
11.16 SANNUO
11.16.1 SANNUO Corporation Information
11.16.2 SANNUO Description, Business Overview and Total Revenue
11.16.3 SANNUO Sales, Revenue and Gross Margin (2015-2020)
11.16.4 SANNUO Products Offered
11.16.5 SANNUO Recent Development
11.17 Yicheng
11.17.1 Yicheng Corporation Information
11.17.2 Yicheng Description, Business Overview and Total Revenue
11.17.3 Yicheng Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Yicheng Products Offered
11.17.5 Yicheng Recent Development
11.18 Yuwell
11.18.1 Yuwell Corporation Information
11.18.2 Yuwell Description, Business Overview and Total Revenue
11.18.3 Yuwell Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Yuwell Products Offered
11.18.5 Yuwell Recent Development
11.19 Greiner Bio One
11.19.1 Greiner Bio One Corporation Information
11.19.2 Greiner Bio One Description, Business Overview and Total Revenue
11.19.3 Greiner Bio One Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Greiner Bio One Products Offered
11.19.5 Greiner Bio One Recent Development
11.20 Edan
11.20.1 Edan Corporation Information
11.20.2 Edan Description, Business Overview and Total Revenue
11.20.3 Edan Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Edan Products Offered
11.20.5 Edan Recent Development
11.21 Narang Medical
11.21.1 Narang Medical Corporation Information
11.21.2 Narang Medical Description, Business Overview and Total Revenue
11.21.3 Narang Medical Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Narang Medical Products Offered
11.21.5 Narang Medical Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Lancets Market Estimates and Projections by Region
12.1.1 Global Lancets Sales Forecast by Regions 2021-2026
12.1.2 Global Lancets Revenue Forecast by Regions 2021-2026
12.2 North America Lancets Market Size Forecast (2021-2026)
12.2.1 North America: Lancets Sales Forecast (2021-2026)
12.2.2 North America: Lancets Revenue Forecast (2021-2026)
12.2.3 North America: Lancets Market Size Forecast by Country (2021-2026)
12.3 Europe Lancets Market Size Forecast (2021-2026)
12.3.1 Europe: Lancets Sales Forecast (2021-2026)
12.3.2 Europe: Lancets Revenue Forecast (2021-2026)
12.3.3 Europe: Lancets Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Lancets Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Lancets Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Lancets Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Lancets Market Size Forecast by Region (2021-2026)
12.5 Latin America Lancets Market Size Forecast (2021-2026)
12.5.1 Latin America: Lancets Sales Forecast (2021-2026)
12.5.2 Latin America: Lancets Revenue Forecast (2021-2026)
12.5.3 Latin America: Lancets Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Lancets Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Lancets Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Lancets Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Lancets Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Lancets Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Lancets Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Lancets Market Segments
Table 2. Ranking of Global Top Lancets Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Lancets Market Size Growth Rate by Type 2020-2026 (M Units) & (US$ Million)
Table 4. Major Manufacturers of Safety Lancets
Table 5. Major Manufacturers of Homecare Lancets
Table 6. COVID-19 Impact Global Market: (Four Lancets Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Lancets Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Lancets Players to Combat Covid-19 Impact
Table 11. Global Lancets Market Size Growth Rate by Application 2020-2026 (M Units)
Table 12. Global Lancets Market Size by Region (M Units) & (US$ Million): 2020 VS 2026
Table 13. Global Lancets Sales by Regions 2015-2020 (M Units)
Table 14. Global Lancets Sales Market Share by Regions (2015-2020)
Table 15. Global Lancets Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Lancets Sales by Manufacturers (2015-2020) (M Units)
Table 17. Global Lancets Sales Share by Manufacturers (2015-2020)
Table 18. Global Lancets Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Lancets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lancets as of 2019)
Table 20. Lancets Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Lancets Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Lancets Price (2015-2020) (USD/K Units)
Table 23. Lancets Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Lancets Product Type
Table 25. Date of International Manufacturers Enter into Lancets Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Lancets Sales by Type (2015-2020) (M Units)
Table 28. Global Lancets Sales Share by Type (2015-2020)
Table 29. Global Lancets Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Lancets Revenue Share by Type (2015-2020)
Table 31. Lancets Average Selling Price (ASP) by Type 2015-2020 (USD/K Units)
Table 32. Global Lancets Sales by Application (2015-2020) (M Units)
Table 33. Global Lancets Sales Share by Application (2015-2020)
Table 34. North America Lancets Sales by Country (2015-2020) (M Units)
Table 35. North America Lancets Sales Market Share by Country (2015-2020)
Table 36. North America Lancets Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Lancets Revenue Market Share by Country (2015-2020)
Table 38. North America Lancets Sales by Type (2015-2020) (M Units)
Table 39. North America Lancets Sales Market Share by Type (2015-2020)
Table 40. North America Lancets Sales by Application (2015-2020) (M Units)
Table 41. North America Lancets Sales Market Share by Application (2015-2020)
Table 42. Europe Lancets Sales by Country (2015-2020) (M Units)
Table 43. Europe Lancets Sales Market Share by Country (2015-2020)
Table 44. Europe Lancets Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Lancets Revenue Market Share by Country (2015-2020)
Table 46. Europe Lancets Sales by Type (2015-2020) (M Units)
Table 47. Europe Lancets Sales Market Share by Type (2015-2020)
Table 48. Europe Lancets Sales by Application (2015-2020) (M Units)
Table 49. Europe Lancets Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Lancets Sales by Region (2015-2020) (M Units)
Table 51. Asia Pacific Lancets Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Lancets Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Lancets Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Lancets Sales by Type (2015-2020) (M Units)
Table 55. Asia Pacific Lancets Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Lancets Sales by Application (2015-2020) (M Units)
Table 57. Asia Pacific Lancets Sales Market Share by Application (2015-2020)
Table 58. Latin America Lancets Sales by Country (2015-2020) (M Units)
Table 59. Latin America Lancets Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Lancets Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Lancets Revenue Market Share by Country (2015-2020)
Table 62. Latin America Lancets Sales by Type (2015-2020) (M Units)
Table 63. Latin America Lancets Sales Market Share by Type (2015-2020)
Table 64. Latin America Lancets Sales by Application (2015-2020) (M Units)
Table 65. Latin America Lancets Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Lancets Sales by Country (2015-2020) (M Units)
Table 67. Middle East and Africa Lancets Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Lancets Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Lancets Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Lancets Sales by Type (2015-2020) (M Units)
Table 71. Middle East and Africa Lancets Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Lancets Sales by Application (2015-2020) (M Units)
Table 73. Middle East and Africa Lancets Sales Market Share by Application (2015-2020)
Table 74. Roche Corporation Information
Table 75. Roche Description and Major Businesses
Table 76. Roche Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 77. Roche Product
Table 78. Roche Recent Development
Table 79. Lifescan Corporation Information
Table 80. Lifescan Description and Major Businesses
Table 81. Lifescan Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 82. Lifescan Product
Table 83. Lifescan Recent Development
Table 84. BD Corporation Information
Table 85. BD Description and Major Businesses
Table 86. BD Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 87. BD Product
Table 88. BD Recent Development
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Major Businesses
Table 91. Bayer Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 92. Bayer Product
Table 93. Bayer Recent Development
Table 94. Abbott Corporation Information
Table 95. Abbott Description and Major Businesses
Table 96. Abbott Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 97. Abbott Product
Table 98. Abbott Recent Development
Table 99. B. Braun Corporation Information
Table 100. B. Braun Description and Major Businesses
Table 101. B. Braun Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 102. B. Braun Product
Table 103. B. Braun Recent Development
Table 104. ARKRAY Corporation Information
Table 105. ARKRAY Description and Major Businesses
Table 106. ARKRAY Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 107. ARKRAY Product
Table 108. ARKRAY Recent Development
Table 109. Terumo Corporation Information
Table 110. Terumo Description and Major Businesses
Table 111. Terumo Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 112. Terumo Product
Table 113. Terumo Recent Development
Table 114. I-SENS Corporation Information
Table 115. I-SENS Description and Major Businesses
Table 116. I-SENS Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 117. I-SENS Product
Table 118. I-SENS Recent Development
Table 119. Nipro Corporation Information
Table 120. Nipro Description and Major Businesses
Table 121. Nipro Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 122. Nipro Product
Table 123. Nipro Recent Development
Table 124. Omron Corporation Information
Table 125. Omron Description and Major Businesses
Table 126. Omron Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 127. Omron Product
Table 128. Omron Recent Development
Table 129. Infopia Corporation Information
Table 130. Infopia Description and Major Businesses
Table 131. Infopia Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 132. Infopia Product
Table 133. Infopia Recent Development
Table 134. AgaMatrix Corporation Information
Table 135. AgaMatrix Description and Major Businesses
Table 136. AgaMatrix Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 137. AgaMatrix Product
Table 138. AgaMatrix Recent Development
Table 139. Smiths Medical Corporation Information
Table 140. Smiths Medical Description and Major Businesses
Table 141. Smiths Medical Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 142. Smiths Medical Product
Table 143. Smiths Medical Recent Development
Table 144. Sarstedt Corporation Information
Table 145. Sarstedt Description and Major Businesses
Table 146. Sarstedt Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 147. Sarstedt Product
Table 148. Sarstedt Recent Development
Table 149. SANNUO Corporation Information
Table 150. SANNUO Description and Major Businesses
Table 151. SANNUO Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 152. SANNUO Product
Table 153. SANNUO Recent Development
Table 154. Yicheng Corporation Information
Table 155. Yicheng Description and Major Businesses
Table 156. Yicheng Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 157. Yicheng Product
Table 158. Yicheng Recent Development
Table 159. Yuwell Corporation Information
Table 160. Yuwell Description and Major Businesses
Table 161. Yuwell Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 162. Yuwell Product
Table 163. Yuwell Recent Development
Table 164. Greiner Bio One Corporation Information
Table 165. Greiner Bio One Description and Major Businesses
Table 166. Greiner Bio One Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 167. Greiner Bio One Product
Table 168. Greiner Bio One Recent Development
Table 169. Edan Corporation Information
Table 170. Edan Description and Major Businesses
Table 171. Edan Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 172. Edan Product
Table 173. Edan Recent Development
Table 174. Narang Medical Corporation Information
Table 175. Narang Medical Description and Major Businesses
Table 176. Narang Medical Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 177. Narang Medical Product
Table 178. Narang Medical Recent Development
Table 179. Global Lancets Sales Forecast by Regions (2021-2026) (M Units)
Table 180. Global Lancets Sales Market Share Forecast by Regions (2021-2026)
Table 181. Global Lancets Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 182. Global Lancets Revenue Market Share Forecast by Regions (2021-2026)
Table 183. North America: Lancets Sales Forecast by Country (2021-2026) (M Units)
Table 184. North America: Lancets Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Europe: Lancets Sales Forecast by Country (2021-2026) (M Units)
Table 186. Europe: Lancets Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Asia Pacific: Lancets Sales Forecast by Region (2021-2026) (M Units)
Table 188. Asia Pacific: Lancets Revenue Forecast by Region (2021-2026) (US$ Million)
Table 189. Latin America: Lancets Sales Forecast by Country (2021-2026) (M Units)
Table 190. Latin America: Lancets Revenue Forecast by Country (2021-2026) (US$ Million)
Table 191. Middle East and Africa: Lancets Sales Forecast by Country (2021-2026) (M Units)
Table 192. Middle East and Africa: Lancets Revenue Forecast by Country (2021-2026) (US$ Million)
Table 193. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 194. Key Challenges
Table 195. Market Risks
Table 196. Main Points Interviewed from Key Lancets Players
Table 197. Lancets Customers List
Table 198. Lancets Distributors List
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
Table 1. Lancets Market Segments
Table 2. Ranking of Global Top Lancets Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Lancets Market Size Growth Rate by Type 2020-2026 (M Units) & (US$ Million)
Table 4. Major Manufacturers of Safety Lancets
Table 5. Major Manufacturers of Homecare Lancets
Table 6. COVID-19 Impact Global Market: (Four Lancets Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Lancets Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Lancets Players to Combat Covid-19 Impact
Table 11. Global Lancets Market Size Growth Rate by Application 2020-2026 (M Units)
Table 12. Global Lancets Market Size by Region (M Units) & (US$ Million): 2020 VS 2026
Table 13. Global Lancets Sales by Regions 2015-2020 (M Units)
Table 14. Global Lancets Sales Market Share by Regions (2015-2020)
Table 15. Global Lancets Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Lancets Sales by Manufacturers (2015-2020) (M Units)
Table 17. Global Lancets Sales Share by Manufacturers (2015-2020)
Table 18. Global Lancets Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Lancets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lancets as of 2019)
Table 20. Lancets Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Lancets Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Lancets Price (2015-2020) (USD/K Units)
Table 23. Lancets Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Lancets Product Type
Table 25. Date of International Manufacturers Enter into Lancets Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Lancets Sales by Type (2015-2020) (M Units)
Table 28. Global Lancets Sales Share by Type (2015-2020)
Table 29. Global Lancets Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Lancets Revenue Share by Type (2015-2020)
Table 31. Lancets Average Selling Price (ASP) by Type 2015-2020 (USD/K Units)
Table 32. Global Lancets Sales by Application (2015-2020) (M Units)
Table 33. Global Lancets Sales Share by Application (2015-2020)
Table 34. North America Lancets Sales by Country (2015-2020) (M Units)
Table 35. North America Lancets Sales Market Share by Country (2015-2020)
Table 36. North America Lancets Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Lancets Revenue Market Share by Country (2015-2020)
Table 38. North America Lancets Sales by Type (2015-2020) (M Units)
Table 39. North America Lancets Sales Market Share by Type (2015-2020)
Table 40. North America Lancets Sales by Application (2015-2020) (M Units)
Table 41. North America Lancets Sales Market Share by Application (2015-2020)
Table 42. Europe Lancets Sales by Country (2015-2020) (M Units)
Table 43. Europe Lancets Sales Market Share by Country (2015-2020)
Table 44. Europe Lancets Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Lancets Revenue Market Share by Country (2015-2020)
Table 46. Europe Lancets Sales by Type (2015-2020) (M Units)
Table 47. Europe Lancets Sales Market Share by Type (2015-2020)
Table 48. Europe Lancets Sales by Application (2015-2020) (M Units)
Table 49. Europe Lancets Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Lancets Sales by Region (2015-2020) (M Units)
Table 51. Asia Pacific Lancets Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Lancets Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Lancets Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Lancets Sales by Type (2015-2020) (M Units)
Table 55. Asia Pacific Lancets Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Lancets Sales by Application (2015-2020) (M Units)
Table 57. Asia Pacific Lancets Sales Market Share by Application (2015-2020)
Table 58. Latin America Lancets Sales by Country (2015-2020) (M Units)
Table 59. Latin America Lancets Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Lancets Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Lancets Revenue Market Share by Country (2015-2020)
Table 62. Latin America Lancets Sales by Type (2015-2020) (M Units)
Table 63. Latin America Lancets Sales Market Share by Type (2015-2020)
Table 64. Latin America Lancets Sales by Application (2015-2020) (M Units)
Table 65. Latin America Lancets Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Lancets Sales by Country (2015-2020) (M Units)
Table 67. Middle East and Africa Lancets Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Lancets Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Lancets Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Lancets Sales by Type (2015-2020) (M Units)
Table 71. Middle East and Africa Lancets Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Lancets Sales by Application (2015-2020) (M Units)
Table 73. Middle East and Africa Lancets Sales Market Share by Application (2015-2020)
Table 74. Roche Corporation Information
Table 75. Roche Description and Major Businesses
Table 76. Roche Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 77. Roche Product
Table 78. Roche Recent Development
Table 79. Lifescan Corporation Information
Table 80. Lifescan Description and Major Businesses
Table 81. Lifescan Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 82. Lifescan Product
Table 83. Lifescan Recent Development
Table 84. BD Corporation Information
Table 85. BD Description and Major Businesses
Table 86. BD Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 87. BD Product
Table 88. BD Recent Development
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Major Businesses
Table 91. Bayer Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 92. Bayer Product
Table 93. Bayer Recent Development
Table 94. Abbott Corporation Information
Table 95. Abbott Description and Major Businesses
Table 96. Abbott Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 97. Abbott Product
Table 98. Abbott Recent Development
Table 99. B. Braun Corporation Information
Table 100. B. Braun Description and Major Businesses
Table 101. B. Braun Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 102. B. Braun Product
Table 103. B. Braun Recent Development
Table 104. ARKRAY Corporation Information
Table 105. ARKRAY Description and Major Businesses
Table 106. ARKRAY Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 107. ARKRAY Product
Table 108. ARKRAY Recent Development
Table 109. Terumo Corporation Information
Table 110. Terumo Description and Major Businesses
Table 111. Terumo Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 112. Terumo Product
Table 113. Terumo Recent Development
Table 114. I-SENS Corporation Information
Table 115. I-SENS Description and Major Businesses
Table 116. I-SENS Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 117. I-SENS Product
Table 118. I-SENS Recent Development
Table 119. Nipro Corporation Information
Table 120. Nipro Description and Major Businesses
Table 121. Nipro Lancets Production (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 122. Nipro Product
Table 123. Nipro Recent Development
Table 124. Omron Corporation Information
Table 125. Omron Description and Major Businesses
Table 126. Omron Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 127. Omron Product
Table 128. Omron Recent Development
Table 129. Infopia Corporation Information
Table 130. Infopia Description and Major Businesses
Table 131. Infopia Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 132. Infopia Product
Table 133. Infopia Recent Development
Table 134. AgaMatrix Corporation Information
Table 135. AgaMatrix Description and Major Businesses
Table 136. AgaMatrix Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 137. AgaMatrix Product
Table 138. AgaMatrix Recent Development
Table 139. Smiths Medical Corporation Information
Table 140. Smiths Medical Description and Major Businesses
Table 141. Smiths Medical Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 142. Smiths Medical Product
Table 143. Smiths Medical Recent Development
Table 144. Sarstedt Corporation Information
Table 145. Sarstedt Description and Major Businesses
Table 146. Sarstedt Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 147. Sarstedt Product
Table 148. Sarstedt Recent Development
Table 149. SANNUO Corporation Information
Table 150. SANNUO Description and Major Businesses
Table 151. SANNUO Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 152. SANNUO Product
Table 153. SANNUO Recent Development
Table 154. Yicheng Corporation Information
Table 155. Yicheng Description and Major Businesses
Table 156. Yicheng Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 157. Yicheng Product
Table 158. Yicheng Recent Development
Table 159. Yuwell Corporation Information
Table 160. Yuwell Description and Major Businesses
Table 161. Yuwell Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 162. Yuwell Product
Table 163. Yuwell Recent Development
Table 164. Greiner Bio One Corporation Information
Table 165. Greiner Bio One Description and Major Businesses
Table 166. Greiner Bio One Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 167. Greiner Bio One Product
Table 168. Greiner Bio One Recent Development
Table 169. Edan Corporation Information
Table 170. Edan Description and Major Businesses
Table 171. Edan Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 172. Edan Product
Table 173. Edan Recent Development
Table 174. Narang Medical Corporation Information
Table 175. Narang Medical Description and Major Businesses
Table 176. Narang Medical Lancets Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2015-2020)
Table 177. Narang Medical Product
Table 178. Narang Medical Recent Development
Table 179. Global Lancets Sales Forecast by Regions (2021-2026) (M Units)
Table 180. Global Lancets Sales Market Share Forecast by Regions (2021-2026)
Table 181. Global Lancets Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 182. Global Lancets Revenue Market Share Forecast by Regions (2021-2026)
Table 183. North America: Lancets Sales Forecast by Country (2021-2026) (M Units)
Table 184. North America: Lancets Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Europe: Lancets Sales Forecast by Country (2021-2026) (M Units)
Table 186. Europe: Lancets Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Asia Pacific: Lancets Sales Forecast by Region (2021-2026) (M Units)
Table 188. Asia Pacific: Lancets Revenue Forecast by Region (2021-2026) (US$ Million)
Table 189. Latin America: Lancets Sales Forecast by Country (2021-2026) (M Units)
Table 190. Latin America: Lancets Revenue Forecast by Country (2021-2026) (US$ Million)
Table 191. Middle East and Africa: Lancets Sales Forecast by Country (2021-2026) (M Units)
Table 192. Middle East and Africa: Lancets Revenue Forecast by Country (2021-2026) (US$ Million)
Table 193. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 194. Key Challenges
Table 195. Market Risks
Table 196. Main Points Interviewed from Key Lancets Players
Table 197. Lancets Customers List
Table 198. Lancets Distributors List
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Lancets Product Picture
Figure 2. Global Lancets Sales Market Share by Type in 2020 & 2026
Figure 3. Safety Lancets Product Picture
Figure 4. Homecare Lancets Product Picture
Figure 5. Global Lancets Sales Market Share by Application in 2020 & 2026
Figure 6. Cholesterol Tests
Figure 7. Glucose Tests
Figure 8. Others
Figure 9. Lancets Report Years Considered
Figure 10. Global Lancets Market Size 2015-2026 (US$ Million)
Figure 11. Global Lancets Sales 2015-2026 (M Units)
Figure 12. Global Lancets Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Lancets Sales Market Share by Region (2015-2020)
Figure 14. Global Lancets Sales Market Share by Region in 2019
Figure 15. Global Lancets Revenue Market Share by Region (2015-2020)
Figure 16. Global Lancets Revenue Market Share by Region in 2019
Figure 17. Global Lancets Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Lancets Revenue in 2019
Figure 19. Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Lancets Sales Market Share by Type (2015-2020)
Figure 21. Global Lancets Sales Market Share by Type in 2019
Figure 22. Global Lancets Revenue Market Share by Type (2015-2020)
Figure 23. Global Lancets Revenue Market Share by Type in 2019
Figure 24. Global Lancets Market Share by Price Range (2015-2020)
Figure 25. Global Lancets Sales Market Share by Application (2015-2020)
Figure 26. Global Lancets Sales Market Share by Application in 2019
Figure 27. Global Lancets Revenue Market Share by Application (2015-2020)
Figure 28. Global Lancets Revenue Market Share by Application in 2019
Figure 29. North America Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 30. North America Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Lancets Sales Market Share by Country in 2019
Figure 32. North America Lancets Revenue Market Share by Country in 2019
Figure 33. U.S. Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 34. U.S. Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 36. Canada Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Lancets Market Share by Type in 2019
Figure 38. North America Lancets Market Share by Application in 2019
Figure 39. Europe Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 40. Europe Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Lancets Sales Market Share by Country in 2019
Figure 42. Europe Lancets Revenue Market Share by Country in 2019
Figure 43. Germany Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 44. Germany Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 46. France Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 48. U.K. Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 50. Italy Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 52. Russia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Lancets Market Share by Type in 2019
Figure 54. Europe Lancets Market Share by Application in 2019
Figure 55. Asia Pacific Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 56. Asia Pacific Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Lancets Sales Market Share by Region in 2019
Figure 58. Asia Pacific Lancets Revenue Market Share by Region in 2019
Figure 59. China Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 60. China Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 62. Japan Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 64. South Korea Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 66. India Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 68. Australia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 70. Taiwan Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 72. Indonesia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 74. Thailand Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 76. Malaysia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 78. Philippines Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 80. Vietnam Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Lancets Market Share by Type in 2019
Figure 82. Asia Pacific Lancets Market Share by Application in 2019
Figure 83. Latin America Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 84. Latin America Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Lancets Sales Market Share by Country in 2019
Figure 86. Latin America Lancets Revenue Market Share by Country in 2019
Figure 87. Mexico Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 88. Mexico Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 90. Brazil Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 92. Argentina Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Lancets Market Share by Type in 2019
Figure 94. Latin America Lancets Market Share by Application in 2019
Figure 95. Middle East and Africa Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 96. Middle East and Africa Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Lancets Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Lancets Revenue Market Share by Country in 2019
Figure 99. Turkey Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 100. Turkey Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 102. Saudi Arabia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 104. UAE Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Lancets Market Share by Type in 2019
Figure 106. Middle East and Africa Lancets Market Share by Application in 2019
Figure 107. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Lifescan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. ARKRAY Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. I-SENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Nipro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Omron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Infopia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. AgaMatrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Smiths Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Sarstedt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. SANNUO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Yicheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Yuwell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Greiner Bio One Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. Edan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 127. Narang Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 128. North America Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 129. North America Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Europe Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 131. Europe Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Asia Pacific Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 133. Asia Pacific Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Latin America Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 135. Latin America Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Middle East and Africa Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 137. Middle East and Africa Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 138. Porter's Five Forces Analysis
Figure 139. Channels of Distribution
Figure 140. Distributors Profiles
Figure 141. Bottom-up and Top-down Approaches for This Report
Figure 142. Data Triangulation
Figure 143. Key Executives Interviewed
Figure 1. Lancets Product Picture
Figure 2. Global Lancets Sales Market Share by Type in 2020 & 2026
Figure 3. Safety Lancets Product Picture
Figure 4. Homecare Lancets Product Picture
Figure 5. Global Lancets Sales Market Share by Application in 2020 & 2026
Figure 6. Cholesterol Tests
Figure 7. Glucose Tests
Figure 8. Others
Figure 9. Lancets Report Years Considered
Figure 10. Global Lancets Market Size 2015-2026 (US$ Million)
Figure 11. Global Lancets Sales 2015-2026 (M Units)
Figure 12. Global Lancets Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Lancets Sales Market Share by Region (2015-2020)
Figure 14. Global Lancets Sales Market Share by Region in 2019
Figure 15. Global Lancets Revenue Market Share by Region (2015-2020)
Figure 16. Global Lancets Revenue Market Share by Region in 2019
Figure 17. Global Lancets Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Lancets Revenue in 2019
Figure 19. Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Lancets Sales Market Share by Type (2015-2020)
Figure 21. Global Lancets Sales Market Share by Type in 2019
Figure 22. Global Lancets Revenue Market Share by Type (2015-2020)
Figure 23. Global Lancets Revenue Market Share by Type in 2019
Figure 24. Global Lancets Market Share by Price Range (2015-2020)
Figure 25. Global Lancets Sales Market Share by Application (2015-2020)
Figure 26. Global Lancets Sales Market Share by Application in 2019
Figure 27. Global Lancets Revenue Market Share by Application (2015-2020)
Figure 28. Global Lancets Revenue Market Share by Application in 2019
Figure 29. North America Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 30. North America Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Lancets Sales Market Share by Country in 2019
Figure 32. North America Lancets Revenue Market Share by Country in 2019
Figure 33. U.S. Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 34. U.S. Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 36. Canada Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Lancets Market Share by Type in 2019
Figure 38. North America Lancets Market Share by Application in 2019
Figure 39. Europe Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 40. Europe Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Lancets Sales Market Share by Country in 2019
Figure 42. Europe Lancets Revenue Market Share by Country in 2019
Figure 43. Germany Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 44. Germany Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 46. France Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 48. U.K. Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 50. Italy Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 52. Russia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Lancets Market Share by Type in 2019
Figure 54. Europe Lancets Market Share by Application in 2019
Figure 55. Asia Pacific Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 56. Asia Pacific Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Lancets Sales Market Share by Region in 2019
Figure 58. Asia Pacific Lancets Revenue Market Share by Region in 2019
Figure 59. China Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 60. China Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 62. Japan Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 64. South Korea Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 66. India Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 68. Australia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 70. Taiwan Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 72. Indonesia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 74. Thailand Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 76. Malaysia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 78. Philippines Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 80. Vietnam Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Lancets Market Share by Type in 2019
Figure 82. Asia Pacific Lancets Market Share by Application in 2019
Figure 83. Latin America Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 84. Latin America Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Lancets Sales Market Share by Country in 2019
Figure 86. Latin America Lancets Revenue Market Share by Country in 2019
Figure 87. Mexico Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 88. Mexico Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 90. Brazil Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 92. Argentina Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Lancets Market Share by Type in 2019
Figure 94. Latin America Lancets Market Share by Application in 2019
Figure 95. Middle East and Africa Lancets Sales Growth Rate 2015-2020 (M Units)
Figure 96. Middle East and Africa Lancets Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Lancets Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Lancets Revenue Market Share by Country in 2019
Figure 99. Turkey Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 100. Turkey Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 102. Saudi Arabia Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Lancets Sales Growth Rate (2015-2020) (M Units)
Figure 104. UAE Lancets Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Lancets Market Share by Type in 2019
Figure 106. Middle East and Africa Lancets Market Share by Application in 2019
Figure 107. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Lifescan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. ARKRAY Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. I-SENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Nipro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Omron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Infopia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. AgaMatrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Smiths Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Sarstedt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. SANNUO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Yicheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Yuwell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Greiner Bio One Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. Edan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 127. Narang Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 128. North America Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 129. North America Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Europe Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 131. Europe Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Asia Pacific Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 133. Asia Pacific Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Latin America Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 135. Latin America Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Middle East and Africa Lancets Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 137. Middle East and Africa Lancets Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 138. Porter's Five Forces Analysis
Figure 139. Channels of Distribution
Figure 140. Distributors Profiles
Figure 141. Bottom-up and Top-down Approaches for This Report
Figure 142. Data Triangulation
Figure 143. Key Executives Interviewed
